Junrui Tian
Overview
Explore the profile of Junrui Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei Z, Cao L, Qiao Z, Luo F, Wang X, Tian J, et al.
Front Public Health
. 2025 Feb;
13:1505825.
PMID: 40008146
Introduction: Parents' negative parenting style is an important cause of anxiety, depression, and suicide among university students. Given the widespread use of social media, microblogs offer a new and promising...
2.
Li Z, Zhang X, Liu C, Wu Y, Wen Y, Zheng R, et al.
Acta Biomater
. 2025 Feb;
PMID: 39920033
No abstract available.
3.
Li Z, Zhang X, Liu C, Wu Y, Wen Y, Zheng R, et al.
Acta Biomater
. 2024 Nov;
191:412-427.
PMID: 39581334
Cancer cell membrane-derived nanoparticle drug delivery system enables precise drug delivery to tumor tissues and is a new effective way to treat solid tumors. The aim of this study is...
4.
Zhang X, Li Z, Peng Q, Liu C, Wu Y, Wen Y, et al.
J Biol Chem
. 2024 Mar;
300(5):107226.
PMID: 38537697
Epstein-Barr virus (EBV) is a human tumor virus associated with a variety of malignancies, including nasopharyngeal carcinoma, gastric cancers, and B-cell lymphomas. N-methyladenosine (mA) modifications modulate a wide range of...
5.
Wen Y, Ye S, Li Z, Zhang X, Liu C, Wu Y, et al.
Cancer Immunol Immunother
. 2024 Jan;
73(1):7.
PMID: 38231305
The search for effective combination therapy with immune checkpoint inhibitors (ICI) has become important for cancer patients who do not respond to the ICI well. Histone deacetylases (HDACs) inhibitors have...
6.
Tian J, Ma J
Pharmaceutics
. 2023 Aug;
15(8).
PMID: 37631352
Tumor neoantigens are widely used in cancer immunotherapy, and a growing body of research suggests that microbes play an important role in these neoantigen-based immunotherapeutic processes. The human body and...
7.
Wu Y, Zhang X, Liu C, Li Z, Wen Y, Zheng R, et al.
J Biol Chem
. 2023 Jul;
299(9):105082.
PMID: 37495108
The development and progression of nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV) infection. NPC is usually asymptomatic until it spreads to other sites, and more than 70%...
8.
Wang T, Gao Y, Wang X, Tian J, Li Y, Yu B, et al.
Chin J Cancer Res
. 2022 Jun;
34(2):95-108.
PMID: 35685992
Objective: Emerging studies have demonstrated the promising clinical value of circulating tumor cells (CTCs) for diagnosis, disease assessment, treatment monitoring and prognosis in epithelial ovarian cancer. However, the clinical application...
9.
Gao Y, Li H, Han Q, Li Y, Wang T, Huang C, et al.
J Cancer
. 2020 Apr;
11(11):3151-3164.
PMID: 32231719
: DUSP6 is a negative regulator of the ERK signaling pathway and plays an important role in chemotherapy-resistance. Previously we showed that DUSP6 is overexpressed in ovarian cancer side population...
10.
Zhang Q, Li H, Mao Y, Wang X, Zhang X, Yu X, et al.
Int J Mol Med
. 2019 Nov;
45(1):10-22.
PMID: 31746376
Ovarian cancer has a high rate of recurrence, with M2 macrophages having been found to be involved in its progression and metastasis. To examine the relationship between macrophages and ovarian...